NCT02520908View on ClinicalTrials.gov

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions

Epidermotropic T-cell Lymphomas

Interventions

PROCEDURE

HSCT

Hematopoietic stem cell transplantation

OTHER

Standard Care

Trial Locations (1)

75010

Saint Louis hospital, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02520908 - Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis | Biotech Hunter | Biotech Hunter